These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 11827300)

  • 41. EPI sentinel surveillance for Kwara, 1982-1987.
    Babaniyi O
    West Afr J Med; 1993; 12(4):218-22. PubMed ID: 8199064
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A school-based measles outbreak: the effect of a selective revaccination policy and risk factors for vaccine failure.
    Hutchins SS; Markowitz LE; Mead P; Mixon D; Sheline J; Greenberg N; Preblud SR; Orenstein WA; Hull HF
    Am J Epidemiol; 1990 Jul; 132(1):157-68. PubMed ID: 2356806
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Progress in measles and rubella elimination in Iran.
    Esteghamati A; Gouya MM; Zahraei SM; Dadras MN; Rashidi A; Mahoney F
    Pediatr Infect Dis J; 2007 Dec; 26(12):1137-41. PubMed ID: 18043452
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Impact of mass measles campaigns among children less than 5 years old in Uganda.
    Nanyunja M; Lewis RF; Makumbi I; Seruyange R; Kabwongera E; Mugyenyi P; Talisuna A
    J Infect Dis; 2003 May; 187 Suppl 1():S63-8. PubMed ID: 12721893
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Role of schools in the transmission of measles in rural Senegal: implications for measles control in developing countries.
    Cisse B; Aaby P; Simondon F; Samb B; Soumaré M; Whittle H
    Am J Epidemiol; 1999 Feb; 149(4):295-301. PubMed ID: 10025469
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Measles epidemic and response in the region of Dakar (Senegal) in 2009].
    Seck I; Faye A; Mbacké Leye MM; Bathily A; Camara MD; Ndiaye P; Dia AT
    Sante Publique; 2012; 24(2):121-32. PubMed ID: 22789117
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Survival of previously measles-vaccinated and measles-unvaccinated children in an emergency situation: an unplanned study.
    Aaby P; Garly ML; Balé C; Martins C; Jensen H; Lisse I; Whittle H
    Pediatr Infect Dis J; 2003 Sep; 22(9):798-805. PubMed ID: 14506371
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effectiveness of vaccination at 6 to 11 months of age during an outbreak of measles.
    de Serres G; Boulianne N; Ratnam S; Corriveau A
    Pediatrics; 1996 Feb; 97(2):232-5. PubMed ID: 8584383
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Measles resurgence following a nationwide measles vaccination campaign in Nigeria, 2005-2008.
    Weldegebriel GG; Gasasira A; Harvey P; Masresha B; Goodson JL; Pate MA; Abanida E; Chevez A
    J Infect Dis; 2011 Jul; 204 Suppl 1():S226-31. PubMed ID: 21666165
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Efficacy of measles vaccine during the 1993 measles epidemic in Korea.
    Kim SK; Son BK; Chung CY; Ahn YM; Park CY; Lee HJ
    Pediatr Infect Dis J; 1995 May; 14(5):346-9. PubMed ID: 7638007
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Epidemiologic consequences of moderate coverage levels of measles vaccine in a district headquarter town (Alwar) in India, 1996.
    Singh J; Gupta RS; Bora D; Meena VR; Jain DC; Khare S; Bhatia R; Sokhey J
    J Trop Pediatr; 1998 Dec; 44(6):369-71. PubMed ID: 9972084
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Measles transmission following the tsunami in a population with a high one-dose vaccination coverage, Tamil Nadu, India 2004-2005.
    Mohan A; Murhekar MV; Wairgkar NS; Hutin YJ; Gupte MD
    BMC Infect Dis; 2006 Sep; 6():143. PubMed ID: 16984629
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Mass measles immunization campaign: experience in the Hong Kong Special Administrative Region of China.
    Chuang SK; Lau YL; Lim WL; Chow CB; Tsang T; Tse LY
    Bull World Health Organ; 2002; 80(7):585-91. PubMed ID: 12163924
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Measles: effect of a two-dose vaccination programme in Catalonia, Spain.
    Godoy P; Domínguez A; Salleras L
    Bull World Health Organ; 1999; 77(2):132-7. PubMed ID: 10083711
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Measles incidence before and after mass vaccination campaigns in Burkina Faso.
    Kambiré C; Konde MK; Yaméogo A; Tiendrébéogo SR; Ouédraogo RT; Otten MW; Cairns KL; Zuber PL
    J Infect Dis; 2003 May; 187 Suppl 1():S80-5. PubMed ID: 12721896
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Two doses of measles vaccine: are some states in India ready for it?
    John S; Sanghi S; Prasad S; Bose A; George K
    J Trop Pediatr; 2009 Aug; 55(4):253-6. PubMed ID: 18799515
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Impact assessment of mass measles vaccination.
    Desai VK; Kapadia SJ; Kumar P; Nirupam S
    Indian J Pediatr; 2002 Dec; 69(12):1037-40. PubMed ID: 12557955
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Impact of measles outbreak response vaccination campaign in Dar es Salaam, Tanzania.
    Goodson JL; Wiesen E; Perry RT; Mach O; Kitambi M; Kibona M; Luman ET; Cairns KL
    Vaccine; 2009 Sep; 27(42):5870-4. PubMed ID: 19656496
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Measles in Europe: an epidemiological assessment.
    Muscat M; Bang H; Wohlfahrt J; Glismann S; Mølbak K;
    Lancet; 2009 Jan; 373(9661):383-9. PubMed ID: 19131097
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Consequences of delayed measles vaccination in Germany.
    Siedler A; Hermann M; Schmitt HJ; Von Kries R
    Pediatr Infect Dis J; 2002 Sep; 21(9):826-30. PubMed ID: 12352803
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.